Business
Vanda Pharmaceuticals Announces Presentations at DDW 2022
WASHINGTON, May 19, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at Digestive Disease Week (DDW) 2022,
About this update from Vanda Pharmaceuticals Inc.
[{"type":"text","content":"WASHINGTON, May 19, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at Digestive Disease Week (DDW) 2022, to be held in San Diego, CA and online from May 21-24, 2022.\nThe following will be presented:\nMay 21, 2022\nPresentation Title: \"THE ROLE OF M1 TO M2 MACROPHAGE POLARIZATION IN THE ETIOLOGY OF IDIOPATHIC GASTROPARESIS: GWAS PERSPECTIVE\"Abstract Number: 3752409Presenter: Dr. Sandra Paulina Smieszek, Head of GeneticsSession Type: Plenary SessionSession Title: Late-Breaking Basic Science Abstract PlenarySession Time: 2:00 PM to 3:30 PM PDTPresentation Time: 2:15 PM to 2:30 PM PDT\nMay 23, 2022\nPresentation Title: \"ENRICHMENT OF PATIENTS WITH EHLERS DANLOS SYNDROME IN IDIOPATHIC GASTROPARESIS – A GENE SET ENRICHMENT ANALYSIS\"Abstract Number: 3696881Presenter: Dr. Sandra Paulina Smieszek, Head of GeneticsSession Type: Poster SessionSession Title: Cell Biology, Biochemistry and Integrative PhysiologySession Time: 12:30 PM to 1:30 PM PDT\nFor more information on DDW 2022, please refer to https://ddw.org/.\nAbout Vanda Pharmaceuticals Inc.Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.\nCorporate Contact: Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc. 202-734-3400 [email protected] \nElizabeth Van Every Head of Corporate Affairs Vanda Pharmaceuticals Inc. 202-734-3400 [email protected] \n View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-presentations-at-ddw-2022-301551750.html\nSOURCE Vanda Pharmaceuticals Inc.","length":3654,"tagName":"div"}]